The nonprofit has an opportunity to tell the story of how the organization adapted to tremendous external changes in the last year.
Smile Train’s top priority remains, as always, the safety and well-being of our beneficiaries, medical partners, friends, family, and global supporters. Since the onset of the COVID-19 pandemic, we estimate that more than 54,000 free, lifesaving cleft surgeries have been put on hold. Where it is safe to do so, we are hard at work resuming surgeries, and our nimble teams have adapted to constantly changing conditions. Since March 2020, we have supported more than 120,000 safe cleft surgeries in 75+ countries, and our partners around the globe are operating at 79% capacity compared to the same period pre-pandemic.
We are continuing to support our international teams based on their unique needs, and many of our local medical partners are still on the ground acting as invaluable resources to their communities.
Smile Train has invested in the distribution of more than $2M in necessary equipment for partners and patients, including personal protective equipment (PPE), handwashing and sanitation facilities, pulse oximeters, non-contact infrared thermometers, masks, and grants to fund COVID testing. We’re making these essential items available to empower partners to continue cleft care while protecting themselves and their patients.
We’ve also increased our investment in grants to cover treatment-related expenses like transportation, lodging, and food for patients and their families.
Where surgeries have been postponed, our providers continue to use telehealth to remain in touch with their patients, helping to care for them even while remaining socially distant. During the pandemic, we have supported 35,000+ sessions of telehealth services to 15,000+ patients.
Since the pandemic began, Smile Train has hosted 3,600+ training sessions, both virtual and in-person, for 26,500+ medical professionals across 89 countries. A great majority of these professionals (23,500+) attended one of 413 virtual sessions.